# P and F Program

> **NIH NIH P30** · UNIVERSITY OF COLORADO DENVER · 2024 · $344,023

## Abstract

PILOT AND FEASIBILITY PROGRAM
SUMMARY/ABSTRACT
The Pilot and Feasibility Program (P&F) is a key component of the UC Denver DRC that will allow DRC
leadership to: 1) recruit new talent into diabetes research, 2) attract established investigators from other
disciplines into diabetes-related scientific pursuits, and 3) support innovative/high-risk diabetes research
projects. Our priority is the support of young, newly independent investigators at the University of Colorado
Anschutz Medical Campus (UC AMC), and its affiliated institutions, who are embarking on diabetes research
careers, but have yet to attain substantial funding. In addition, the UC Denver DRC P&F Program is an important
means of promoting interdisciplinary diabetes research by fostering collaboration between DRC members and
improving university-wide interactions between DRC members and other UC Denver NIH Centers or Dean’s
Initiatives. The P&F program will also serve as a mechanism to increase the diversity of the UC AMC diabetes
research community and its research portfolio. We will achieve these goals through the following specific aims:
AIM 1: To establish a transparent and streamlined process for grant solicitation, scientific review, funding, project
guidance/management, and progress assessment.
AIM 2: To enhance the UC AMC diabetes research community and diversify its innovative research portfolio by
providing funding to: a) early career diabetes investigators who lack substantial research funding; b) established
investigators from other fields that intend to apply their knowledge and expertise to investigation of diabetes-
related topic(s); c) established diabetes investigators who propose innovative, high-risk projects that deviate
from their current funded research programs, and that would be unlikely to be funded through the usual granting
agencies without compelling preliminary data; d) develop novel models (i.e. organoids) to examine unique
physiological targets such as sex as a biological variable and immunomodulation.
AIM 3: To provide career guidance and a scientific home for P&F funded investigators.
AIM 4: To formally evaluate the impact of the UC Denver DRC P&F Program on individual grant recipients, as
well as on the UC AMC diabetes research community as a whole.

## Key facts

- **NIH application ID:** 10833187
- **Project number:** 5P30DK116073-05
- **Recipient organization:** UNIVERSITY OF COLORADO DENVER
- **Principal Investigator:** JANE E REUSCH
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $344,023
- **Award type:** 5
- **Project period:** 2020-04-01 → 2025-08-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10833187

## Citation

> US National Institutes of Health, RePORTER application 10833187, P and F Program (5P30DK116073-05). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10833187. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*